首页> 外文会议>The Seventh China-Japan joint symposium on enzyme engineering >Non-Protein Amino Acid Production Using Recombinant E. colis
【24h】

Non-Protein Amino Acid Production Using Recombinant E. colis

机译:使用重组大肠杆菌生产非蛋白质氨基酸

获取原文
获取原文并翻译 | 示例

摘要

In the microbial and plant cells, L-Cys is synthesized from L-Ser by the two-step enzymatic pathway, in which serine acetyltransferase (SAT) catalyzes the formation of O-aeetyl-L-Ser (OAS) and CoA from L-Ser and aeetyl-CoA, while O-acetylserine sulfhydrylase-A (OASS) converts OAS with sulfide (SH~-) to L-Cys and acetic acid (1). Instead of sulfide, various nucleophiies such as derivatives of heterocyclic compounds such as pyrazole could be utilized as the substrate to produce non-protein amino acids (2-4). However, to synthesize effectively non-protein amino acids such as β-(pylazol-1-yl)- L-alanine (β-PA), regeneration of CoA to acetyl-CoA is necessary. Previously, we synthesized enzymatically β-PA using SATΔC20 (5), OASS-A, and phosphotransacetylase (PTA) with acetyl phosphate (AcP) as the substrate to regenerate acetyl-CoA. SATΔC20 is a mutant SAT deleting 20 amino acids from the C-terminus, which looses ability to form a complex with OASS and thus the OASS activity is not repressed in the presence of SAT (6-9). We optimized the reaction conditions on the basis of kinetic studies to synthesize β-PA from 200 mM L-Ser, 200 mM pyrazole, and 200 mM AcP with a yield higher than 70%. In this study, we intended to optimize β-PA production from L-Ser and pyrazole using recombinant Escherichia colis transformed with different plasmids.
机译:在微生物和植物细胞中,L-Cys通过两步酶促途径从L-Ser合成,其中丝氨酸乙酰转移酶(SAT)催化L-Ser(OAS)和CoA的形成。 Ser和十六烷基CoA,而O-乙酰基丝氨酸巯基化酶A(OASS)将带有硫化物(SH〜-)的OAS转化为L-Cys和乙酸(1)。代替硫化物,可以将各种核仁如杂环化合物的衍生物如吡唑用作底物以产生非蛋白质氨基酸(2-4)。但是,为了有效合成非蛋白质氨基酸,例如β-(吡唑-1-基)-L-丙氨酸(β-PA),必须将CoA再生为乙酰-CoA。以前,我们以乙酰基磷酸酯(AcP)为底物,使用SATΔC20(5),OASS-A和磷酸转乙酰酶(PTA)酶促合成β-PA,以再生乙酰基-CoA。 SATΔC20是从C末端删除20个氨基酸的突变SAT,它失去了与OASS形成复合物的能力,因此在存在SAT时不抑制OASS活性(6-9)。我们在动力学研究的基础上优化了反应条件,以200 mM L-Ser,200 mM吡唑和200 mM AcP合成β-PA,收率高于70%。在这项研究中,我们打算使用通过不同质粒转化的重组大肠杆菌优化L-Ser和吡唑的β-PA产量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号